Shengqing Jiangzhuo capsule ameliorates diabetic nephropathy by improving Keap1/Nrf2 signaling pathway.
Yanna YuMin LiWeijie LaiXin DongShu ZhangLiangyou ZhangGangyi ChenPublished in: The Journal of pharmacy and pharmacology (2024)
These findings suggest that SQJZJN exerts a protective effect on DN, potentially through the activation of the Keap1/Nrf2/ARE pathway.